Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies
- Author
- Miffy H. Y. Cheng, Cedric A. Brimacombe, Rein Verbeke (UGent) and Pieter R. Cullis
- Organization
- Abstract
- In this brief perspective, we describe key events in the history of the lipid-based nanomedicine field, highlight Canadian contributions, and outline areas where lipid nanoparticle technology is poised to have a transformative effect on the future of medicine.
- Keywords
- Drug Discovery, Pharmaceutical Science, Molecular Medicine, lipid nanoparticles, gene therapy, mRNA, vaccines, CAR-T therapy, CRISPR-Cas9, LARGE UNILAMELLAR VESICLES, MESSENGER-RNA VACCINES, IN-VIVO, LIPOSOMES, PCSK9, SIRNA, CHOLESTEROL, PROTECTION, DRUGS, LDL
Downloads
-
Mol Pharm Perspective Resubmission.docx
- full text (Accepted manuscript)
- |
- open access
- |
- ZIP archive
- |
- 1.32 MB
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 1.73 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GM25MB0PQF7FSTRTBVC93QMT
- MLA
- Cheng, Miffy H. Y., et al. “Exciting Times for Lipid Nanoparticles : How Canadian Discoveries Are Enabling Gene Therapies.” MOLECULAR PHARMACEUTICS, vol. 19, no. 6, 2022, pp. 1663–68, doi:10.1021/acs.molpharmaceut.2c00365.
- APA
- Cheng, M. H. Y., Brimacombe, C. A., Verbeke, R., & Cullis, P. R. (2022). Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies. MOLECULAR PHARMACEUTICS, 19(6), 1663–1668. https://doi.org/10.1021/acs.molpharmaceut.2c00365
- Chicago author-date
- Cheng, Miffy H. Y., Cedric A. Brimacombe, Rein Verbeke, and Pieter R. Cullis. 2022. “Exciting Times for Lipid Nanoparticles : How Canadian Discoveries Are Enabling Gene Therapies.” MOLECULAR PHARMACEUTICS 19 (6): 1663–68. https://doi.org/10.1021/acs.molpharmaceut.2c00365.
- Chicago author-date (all authors)
- Cheng, Miffy H. Y., Cedric A. Brimacombe, Rein Verbeke, and Pieter R. Cullis. 2022. “Exciting Times for Lipid Nanoparticles : How Canadian Discoveries Are Enabling Gene Therapies.” MOLECULAR PHARMACEUTICS 19 (6): 1663–1668. doi:10.1021/acs.molpharmaceut.2c00365.
- Vancouver
- 1.Cheng MHY, Brimacombe CA, Verbeke R, Cullis PR. Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies. MOLECULAR PHARMACEUTICS. 2022;19(6):1663–8.
- IEEE
- [1]M. H. Y. Cheng, C. A. Brimacombe, R. Verbeke, and P. R. Cullis, “Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies,” MOLECULAR PHARMACEUTICS, vol. 19, no. 6, pp. 1663–1668, 2022.
@article{01GM25MB0PQF7FSTRTBVC93QMT,
abstract = {{In this brief perspective, we describe key events in the history of the lipid-based nanomedicine field, highlight Canadian contributions, and outline areas where lipid nanoparticle technology is poised to have a transformative effect on the future of medicine.}},
author = {{Cheng, Miffy H. Y. and Brimacombe, Cedric A. and Verbeke, Rein and Cullis, Pieter R.}},
issn = {{1543-8384}},
journal = {{MOLECULAR PHARMACEUTICS}},
keywords = {{Drug Discovery,Pharmaceutical Science,Molecular Medicine,lipid nanoparticles,gene therapy,mRNA,vaccines,CAR-T therapy,CRISPR-Cas9,LARGE UNILAMELLAR VESICLES,MESSENGER-RNA VACCINES,IN-VIVO,LIPOSOMES,PCSK9,SIRNA,CHOLESTEROL,PROTECTION,DRUGS,LDL}},
language = {{eng}},
number = {{6}},
pages = {{1663--1668}},
title = {{Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies}},
url = {{http://doi.org/10.1021/acs.molpharmaceut.2c00365}},
volume = {{19}},
year = {{2022}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: